Home Health Care News Petition Asks FDA to Green-Light Early HCQ Treatment

Petition Asks FDA to Green-Light Early HCQ Treatment

Clinicians, medical researchers, statisticians, and ethicists are urging the U.S. Food and Drug Administration (FDA) to expand the use of hydroxychloroquine (HCQ) in early outpatient treatment settings.

A consortium of physicians led by Peter McCullough, M.D. and Kevin Wheelan, M.D, at Baylor University Medical Center are circulating a petition stating the current protocol for the drug’s use is a “failure.” Treatment protocals based on FDA guidance require COVID-infected patients to wait at home until they experience shortness of breath and are admitted into a hospital.

“It is unrealistic to believe that a continuation of this doctrine will have any practical effect in halting the epidemiological spread and significantly reducing the mortality rate of COVID-19,” the petition states.

The signees are asking FDA to grant emergency use authorization for HCQ that would include allow physicians to prescribe the drug based on their clinical judgement; a continuation of studies that would include measuring the effect of HCQ before infection or symptoms appear,  the establishment of a prophylactic HCQ program for health care workers, first responders and other high risk groups and permission to health care professionals to administer the drug during case-contact tracing.

“What we need is for the FDA to announce that the drug is safe and recommended for specific COVID situations,” says Meryl Nass, M.D., a board member of the Alliance for Human Research Protection. Nass says such an acknowledgement by the FDA would eliminate liability problems physicians would still face even under a new EUA.

—Staff reports

Internet info:

Support for the Request for Emergency Use Authorization of Hydroxychloroquine for Ambulatory, Prophylaxis and Treatment of COVID-19: https://hcqpetition.com

1 COMMENT

  1. Absurd protocol will harm not help. If you are sick should you wait till you are sicker to begin therapy? “the current protocol for the drug’s use is a “failure.” Treatment protocals based on FDA guidance require COVID-infected patients to wait at home until they experience shortness of breath and are admitted into a hospital.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

COVID-19 Shutdowns, Internet Connectivity Yet Again Show Superiority of Small Government

The China Virus shutdowns have even more acutely and starkly highlighted the differences between Big Government states and Less Government states.

Federal Court Denies Oakland’s Efforts to Block Coal Shipments to Port Terminal

California Attorney General, Xavier Becerra, has lost the latest bid by public officials in the state to block shipments of coal through the Oakland Bulk and Oversized Terminal.

COVID Will Worsen M.D. Residency Shortage, Study Finds

The COVID-19 pandemic is putting additional stress on the program that matches medical school graduates to residency programs, further straining the supply of trained physicians, a new study finds.

Border Wall Spending and Construction can Proceed, Rules the U.S. Supreme Court

The United States Supreme Court has rejected a challenge raised by environmental organizations to the Trump administration’s continued construction of a wall along the U.S. border between Mexico and the United States.
- Advertisement -

Recent Comments